Viral Trigger for Celiac Disease?

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show.

Written byAnna Azvolinsky
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Left: Normally, a regulatory immune response blocks inflammation to dietary antigens. Right: When reovirus penetrates at the site where dietary gluten is present, it induces danger signals that confuse the immune system and lead it to develop an aggressive inflammatory immune response against gluten, which may trigger celiac disease.UNIVERSITY OF CHICAGO; VALÉRIE ABADIE, BANA JABRIOrally infecting mice with a human reovirus resulted in an immune response against gluten and led to symptoms of celiac disease in the rodents, researchers reported today (April 6) in Science. Reoviruses are prevalent in humans; while children are commonly infected with them, reoviruses are not known to cause disease in people. But the results of this mouse study suggest that a reovirus infection may spur development of celiac disease in certain individuals.

“It’s been hypothesized for decades that virus infection can trigger autoimmune processes. This study provides an example of that phenomenon and some mechanistic insight into how this might work for celiac disease,” said Herbert Virgin, a virologist at the University of Washington, who has collaborated with some of the study’s authors but was not involved in the present work.

An inflammatory immune response develops in the guts of individuals with celiac disease when they ingest foods containing gluten, a protein found in wheat. People with celiac disease have a genetic predisposition to gluten intolerance, but prior epidemiological data provided hints that environmental factors, including viral infections, are also associated with initiation of the disorder.

To test the role of a human reovirus in stimulating celiac ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies